GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.

Revenue
+7.19%
EPS
+40.6%
Free cash flow
+64.2%
Total debt
−1.90%

Quarter to September 2026, against a year earlier

82.39 1.36 −1.62%
Market cap
$37.9B
P/E
17.5×
Fwd P/E
15.5×
Dividend yield
0.17%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
13.74 14.68 17.03 17.99

+8 more quarters

P/S ratio
1.37 1.36 1.55 1.81
P/FCF ratio
15.64 18.36 21.37 24.85
P/Operating CF
32.58 172.60 111.92 35.62
P/B ratio
2.54 2.64 3.04 3.60
EV/Sales
1.77 1.81 1.99 2.16
EV/EBITDA
10.91 11.50 12.86 13.34
EV/FCF
20.27 24.33 27.47 29.61
Current Ratio
1.30 1.26 1.22 1.37
Net Debt/EBITDA
9.04 10.49 13.87 7.34
Debt/Equity
1.00 1.05 1.08 1.12
Earnings Yield
7.28% 6.81% 5.87% 5.56%
Free Cash Flow Yield
6.39% 5.45% 4.68% 4.02%
Free Cash Flow per Share
1.75 0.15 0.25 2.01
Book value per Share
25.73 24.26 23.42 22.79
Free Cash Flow
793.00 68.00 112.00 916.00
EV/EBIT
13.26 14.05 15.75 16.13
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026